🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT06490809
Recruiting Not applicable

Minimal Clinically Important Difference of the Box and Block Test in Parkinson

NCT06490809 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2024-10-01
Last updated
2025-03-05

Condition(s) studied

Parkinson Disease

Investigational drug(s) / intervention(s)

Physiotherapy

Physiotherapy: Parkinson\'s upper extremity rehabilitation generally consists of stretching, strengthening, coordination, recreational activities and skill activities. Exercises will be prescribed by the clinical specialist physician and physiotherapist.

Study summary

The aim of this study is to examine the level of clinical change in gross manual skills of Parkinson's patients who receive conventional physiotherapy. For this purpose, the Box-Block Test will be used, and the amount of change that must occur in the patient's hand functions will be determined for the test to be considered clinically meaningful.

Patients will continue their routine physical therapy sessions and the researchers will not interfere with this program. The treatment program will be created by the clinical specialist physician and physiotherapist.

Upper extremity rehabilitation programs for Parkinson's patients generally consist of methods such as stretching, strengthening, reaching, coordination and recreational activities. Patients will receive physiotherapy for 30 sessions.

Eligibility

Sex
ALL
Min age
50 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: * Being Hoehn \& Yahr Stage between 1-3, * Individuals in the "On" phase, * Those who were not exposed to any physiotherapy intervention during the initial assessment Exclusion Criteria: * Mini-mental status assessment \< 24 points; * Presence of severe dyskinesia, * Those who experience fluctuations in the on-off phase, * Those who have undergone stereotaxic brain surgery for Parkinson's, * Individuals with changes in dopamine dose within three months, * Presence of unstable cardiac and respiratory disease * Those with an orthopedic problem or a history of surgery affecting upper extremity performance.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Özel Öz İstanbul Tıp Merkezi Istanbul Turkey (Türkiye) Recruiting

More Emre Şenocak trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06490809 on ClinicalTrials.gov ↗ ← All trials in Turkey